Pilot study on the feasibility of PET/CT lymphoscintigraphy with 89Zr-nanocolloidal albumin for sentinel node identification in oral cancer patients

J Nucl Med. 2013 Apr;54(4):585-9. doi: 10.2967/jnumed.112.115188. Epub 2013 Feb 1.

Abstract

With conventional imaging techniques such as planar lymphoscintigraphy and SPECT/CT, preoperative sentinel node (SN) identification can be difficult when the SN is near the primary tumor, as is the case in floor-of-mouth carcinomas. PET/CT lymphoscintigraphy may improve the detection and localization of such SNs.

Methods: In this study, the clinical feasibility of PET/CT lymphoscintigraphy using (89)Zr-nanocolloidal albumin was evaluated in 5 oral cancer patients. PET/CT lymphoscintigraphy was performed after peritumoral injection of (89)Zr-nanocolloidal albumin. The routine SN procedure, including SPECT/CT using (99m)Tc-nanocolloidal albumin, was performed on the same patients 7-9 d after the injection of (89)Zr-nanocolloidal albumin.

Results: Comparison of radiocolloid distribution on PET/CT and SPECT/CT showed identical drainage patterns. Moreover, PET/CT was able to identify additional foci near the primary tumor.

Conclusion: This pilot PET/CT study on SN detection indicated that lymphoscintigraphy using (89)Zr-nanocolloidal albumin is feasible.

MeSH terms

  • Feasibility Studies
  • Humans
  • Lymphatic Metastasis
  • Lymphoscintigraphy / methods*
  • Mouth Neoplasms / diagnostic imaging
  • Mouth Neoplasms / pathology*
  • Multimodal Imaging / methods*
  • Nanostructures*
  • Neoplasm Staging
  • Pilot Projects
  • Positron-Emission Tomography*
  • Radioisotopes*
  • Technetium Tc 99m Aggregated Albumin* / chemistry
  • Tomography, X-Ray Computed*
  • Zirconium*

Substances

  • Radioisotopes
  • Technetium Tc 99m Aggregated Albumin
  • Zirconium